We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

84 hedge funds and large institutions have $360M invested in Korro Bio in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

136% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 14

26% more capital invested

Capital invested by funds: $285M → $360M (+$74.3M)

18% more funds holding

Funds holding: 71 → 84 (+13)

9.03% more ownership

Funds ownership: 91.8% → 100.82% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
84
Holders Change
+13
Holders Change %
+18.31%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
33
Reduced
14
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$36.3M
2
DCM
Driehaus Capital Management
Illinois
+$17.5M
3
WP
Woodline Partners
California
+$5.25M
4
Franklin Resources
Franklin Resources
California
+$4.72M
5
TLP
Tri Locum Partners
New York
+$4.12M

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$14.1M
2
CAM
Cormorant Asset Management
Massachusetts
-$8.88M
3
Citadel Advisors
Citadel Advisors
Florida
-$8.19M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.43M
5
Verition Fund Management
Verition Fund Management
Connecticut
-$1.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$43.3M – – –
NMC
2
NEA Management Company
Maryland
$41.5M – – –
DTC
3
Deep Track Capital
Connecticut
$33.3M +$1.26M +24,614 +3%
AllianceBernstein
4
AllianceBernstein
Tennessee
$26.9M +$36.3M +705,794 New
Fidelity Investments
5
Fidelity Investments
Massachusetts
$24.4M +$3.2M +62,176 +11%
DCM
6
Driehaus Capital Management
Illinois
$18.8M +$17.5M +340,410 +220%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$18.8M +$2.53M +49,147 +11%
BlackRock
8
BlackRock
New York
$17.2M +$128K +2,499 +0.6%
SL
9
Siren LLC
Connecticut
$15.9M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$14.8M -$2.43M -47,371 -11%
Citadel Advisors
11
Citadel Advisors
Florida
$14.1M -$8.19M -159,440 -30%
QUSVM
12
Qiming U.S. Ventures Management
Washington
$14M – – –
7IH
13
72 Investment Holdings
Connecticut
$10.5M – – –
TLP
14
Tri Locum Partners
New York
$5.49M +$4.12M +80,202 +125%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$5.22M -$21.1K -410 -0.3%
State Street
16
State Street
Massachusetts
$4.72M +$273K +5,314 +4%
EAM
17
Eventide Asset Management
Massachusetts
$4.48M -$14.1M -273,610 -70%
SSA
18
Schonfeld Strategic Advisors
New York
$4.3M -$1.52M -29,580 -21%
WP
19
Woodline Partners
California
$3.89M +$5.25M +102,094 New
Millennium Management
20
Millennium Management
New York
$3.65M +$1.21M +23,547 +33%
Franklin Resources
21
Franklin Resources
California
$3.49M +$4.72M +91,757 New
PCH
22
Polar Capital Holdings
United Kingdom
$2.86M +$3.85M +75,000 New
UBS Group
23
UBS Group
Switzerland
$2.78M +$3.25M +63,309 +651%
ABG
24
Ally Bridge Group
New York
$2.69M +$3.63M +70,678 New
Verition Fund Management
25
Verition Fund Management
Connecticut
$2.36M -$1.6M -31,195 -33%
1
2 3 4

KRRO Hedge Fund Activity: Q4 2024 in Review

84 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2024, worth a combined $360M — up 26% from $285M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new KRRO positions and 9 closed out — a net gain of 15 holders — while 33 added to existing stakes and 14 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $36.3M. The largest seller was Eventide Asset Management, cutting an estimated $14.1M.

  • 84 institutional investors held Korro Bio (KRRO) as of Q4 2024, up from 71 in Q3 2024.
  • Funds reported $360M of Korro Bio stock for Q4 2024, up 26% quarter-over-quarter.
  • 24 funds opened new Korro Bio positions in Q4 2024 and 9 closed out, a net change of +15 holders.
  • The largest Korro Bio buyer in Q4 2024 was AllianceBernstein, an estimated $36.3M added.
  • The largest Korro Bio seller in Q4 2024 was Eventide Asset Management, an estimated $14.1M sold.

Based on aggregated 13F filings for Q4 2024.